8-K - PRKA - Equibles

UNITED

STATES

SECURITIES

AND EXCHANGE COMMISSION

Washington,

D.C. 20549

FORM

8-K

CURRENT

REPORT

PURSUANT

TO SECTION 13 OR 15(D) OF THE

SECURITIES

EXCHANGE ACT OF 1934

June6, 2024	000-51254
Date<br> of Report (Date of earliest event reported)	Commission<br> File Number

PARKS!

AMERICA, INC.

(Exact name of registrant as specified in its charter)

Nevada	91-0626756
(State<br> or other jurisdiction of <br><br> incorporation or organization)	(I.R.S.<br> Employer <br><br> Identification Number)

1300Oak Grove Road

PineMountain, GA 31822

(Address of Principal Executive Offices) (Zip Code)

(706)663-8744

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written<br> communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting<br> material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement<br> communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement<br> communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities

registered pursuant to Section 12(g) of the Act:

Title<br> of each class	Trading<br> Symbol(s)	Name<br> of each exchange on which registered
Common<br> Stock	PRKA	OTCPink

Item5.07. Submission of Matters to a Vote of Security Holders

On June 6, 2024, Parks! America, Inc. (the “Company”) held its 2024 Annual Meeting of Stockholders (the “Annual Meeting”). The purpose of the Annual Meeting was for the Company’s stockholders to elect seven (7) nominees to serve on the Company’s Board of Directors (the “Board”), as well as to consider and vote on four (4) additional proposals. The nominees for director included six (6) nominees proposed by the Company and four (4) nominees proposed by Focused Compounding Fund, LP (“Focused Compounding”). The Annual Meeting also included three (3) proposals from the Company, as well as one (1) proposal submitted by Focused Compounding, for stockholder consideration and voting.

At the close of business on May 13, 2024, the record date for the determination of stockholders entitled to vote at the Annual Meeting, there were 75,726,851 shares of Common Stock issued and outstanding, each share being entitled to one vote. At the Annual Meeting, the holders of 68,014,921 shares of the Company’s Common Stock, or approximately 89.8% of the outstanding Common Stock, were represented in person or by proxy, and, therefore, a quorum was present.

At the Annual Meeting, the Company’s stockholders voted on the following matters:

1.	Proposal 1: Elect seven (7) nominees to serve on the<br> Board, each for a term of one (1) year or until his or her respective successor is duly elected and qualified;